| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,091 | 35,667 | 31,234 | 33,869 | | Cost of Revenue | 7,969 | 8,605 | 8,874 | 9,633 | | | Gross Profit |
-
| 27,062 | 22,360 | 24,236 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 19,159 | 16,117 | 15,846 | 12,011 | | Non Recurring | 52,395 |
-
|
-
| 57,800 | | Others | 13,131 | 9,888 | 14,065 | 15,492 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,057 | (7,551) | (61,067) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (65,563) | 1,057 | (7,551) | (61,067) | | Interest Expense | 2,111 | 2,202 | 2,340 | 2,975 | | Income Before Tax | (67,674) | (1,145) | (9,891) | (64,042) | | Income Tax Expense | (184) | (742) | (4,124) | (3,481) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (67,490) | (403) | (5,767) | (60,561) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (67,490) | (403) | (5,767) | (60,561) | | Preferred Stock And Other Adjustments | (815) | (809) | (431) |
-
| | | Net Income Applicable To Common Shares | ($68,305) | ($1,212) | ($6,198) | ($60,561) |
|
0.51% Nasdaq 
0.06 (4.26%) 
Income Statement
